Haemolysis is a concerning bias in some ozone therapy approaches
Int Immunopharmacol
.
2024 Dec 25;143(Pt 3):113512.
doi: 10.1016/j.intimp.2024.113512.
Epub 2024 Nov 4.
Authors
Marianno Franzini
1
,
Luigi Valdenassi
1
,
Umberto Tirelli
2
,
Francesco Vaiano
1
,
Salvatore Chirumbolo
3
Affiliations
1
Italian Scientific Society of Oxygen-Ozone Therapy (SIOOT) and High Master School of Oxygen-Ozone Therapy, University of Pavia, Italy.
2
Tirelli Medical Group, Pordenone and Former Head Director of the Oncology Unit at the Cancer Research Institute, Aviano, Pordenone, Italy.
3
Department of Engineering for Innovation Medicine, University of Verona, Italy. Electronic address:
[email protected]
.
PMID:
39500080
DOI:
10.1016/j.intimp.2024.113512
No abstract available
Publication types
Letter